Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid organ transplant: medication management issues.

J Trofe1, S Wimberley

  • 1Division of Transplantation, University of Tennessee College of Pharmacy, Memphis, USA.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|October 13, 2000
PubMed
Summary

Solid organ transplant recipients live longer, but chronic rejection is a challenge. Optimizing immunosuppression with newer agents and pharmacist support can prevent complications and improve long-term outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients.

Transplant infectious disease : an official journal of the Transplantation Society·2006
Same author

Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.

Transplantation proceedings·2005
Same author

Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.

Transplantation proceedings·2005
Same author

Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection.

Transplantation proceedings·2005
Same author

A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.

Transplantation proceedings·2005
Same author

Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.

Transplantation proceedings·2005

Area of Science:

  • Transplantation Medicine
  • Immunology
  • Pharmacology

Background:

  • Solid organ transplant survival rates have improved significantly.
  • Acute rejection incidence has decreased, but chronic rejection persists.
  • Current immunosuppression strategies require balancing rejection prevention and complication management.

Purpose of the Study:

  • To review current challenges in solid organ transplantation.
  • To highlight the importance of comprehensive immunosuppression goals.
  • To discuss the role of novel immunosuppressive agents and pharmacists in improving patient outcomes.

Main Methods:

  • Literature review of recent advancements in transplantation and immunosuppression.
  • Analysis of current trends in acute and chronic rejection.
  • Examination of the impact of newer immunosuppressive therapies.

Main Results:

  • Improved long-term survival and quality of life in transplant patients.
  • Chronic rejection remains a significant clinical issue.
  • Newer immunosuppressive agents offer improved efficacy with reduced adverse effects.

Conclusions:

  • Immunosuppression management must address both rejection and post-transplant complications.
  • Pharmacist involvement is crucial for optimizing immunosuppressive therapy and patient outcomes.
  • Future strategies should leverage advanced immunosuppressive agents for better long-term transplant success.

Related Experiment Videos